Abstract: This podcast presents an overview of new therapies on the horizon for breast cancer in terms of data presented at the European Society for Medical Oncology Congress, American Society of Clinical Oncology and the San Antonio Breast Cancer Symposium. In the adjuvant setting, results from the Microarray In Node negative Disease may Avoid ChemoTherapy (MINDACT) trial,SigueSigue leyendo «New horizon in breast cancer therapy: highlights from the European Society for Medical Oncology. Open Access.»